New supplement aims to soothe menstrual cramps without drugs
NCT ID NCT07529561
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tests whether a dietary supplement called CL25216 can help women with painful periods (primary dysmenorrhea). Eighty healthy women aged 25-40 will take either CL25216 or a placebo daily for 84 days. Researchers will measure changes in menstrual pain, pain duration, and sexual function using questionnaires.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY DYSMENORRHEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
DEC Healthcare Hospital,
Nellore, Andhra Pradesh, India
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CL25216 (a dietary supplement)
What this could lead to
If it works, this could offer a natural option for reducing period pain and improving menstrual health.
What could go wrong
This is an early-stage trial with only 80 participants, and it's not yet recruiting. The supplement may not work better than a placebo, and results may not apply to all women.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.